Pastel
BioScience has developed a number of novel patented
technologies which while relevant to the InVenio™ biomarker
discovery & validation platform are potentially useful
technologies in their own right and suitable for outlicensing to
generate revenues for Pastel's continued internal development
programmes.
Pastel has already entered into a royalty bearing patent license
agreement, with a major European Diagnostics manufacturer, for part of
its
technology and is actively seeking to outlicense additional
technologies and develop its product portfolio via corporate
collaborations and internal development
programs.
